This observation is consistent with observation reported for other AML models, where PTEN loss has been attributed to LSC-inducing mutations (16), as well models where upregulated AKT/mTOR has contributed to depletion of HSC pools through purported changes to proliferation, differentiation, and survival (38). Here, MTOR is linked to acute myeloid leukemia.